Modern pharmaceutical development is no longer focused solely on discovering new molecules. Increasingly, companies are investing significant resources in reformulating known active pharmaceutical ingredients (APIs) to improve their efficacy, stability, safety profile, or patient experience. In this context, drug dissolution problems have become a critical factor influencing the success of many pharmaceutical developments, as they directly affect the release and absorption of the active ingredient.
What are dissolution problems in pharmacology?
Dissolution problems occur when an active pharmaceutical ingredient does not dissolve adequately in biological fluids, particularly in the gastrointestinal tract.
Dissolution is a critical step that takes place before drug absorption. If a medication does not dissolve properly, its bioavailability may be significantly reduced, directly affecting its clinical efficacy.
Dissolution as an essential step before absorption
When a medication is administered orally, the active ingredient must pass through several stages before reaching the bloodstream. One of the most important is its ability to dissolve in gastrointestinal fluids.
Without this preliminary step, drug absorption can be significantly reduced.
Various pharmacokinetic studies estimate that approximately 40% of marketed active pharmaceutical ingredients and up to 90% of candidate molecules under investigation exhibit solubility or dissolution-related issues. This phenomenon has become one of the pharmaceutical industry’s greatest challenges over recent decades.
The situation is particularly complex because many innovative molecules possess more sophisticated chemical structures and physicochemical properties that make their behavior in aqueous environments more difficult to manage.
Pharmaceutical reformulation: Much more than changing the dosage form
Pharmaceutical reformulation is not simply about converting a tablet into a capsule or modifying a dosage strength.
Its objective is to optimize critical properties such as:
- Absorption rate
- Bioavailability
- Chemical stability
- Release profile
- Tolerability
- Patient adherence
In many cases, dissolution problems are the starting point for these pharmaceutical development projects.
A drug may perform well under laboratory conditions but behave differently during industrial-scale manufacturing or under real-world usage conditions.
Main causes of dissolution problems
Poor solubility does not depend on a single factor. It results from a combination of physicochemical properties and biological environmental conditions.
Among the most relevant factors are:
- Crystalline form of the active ingredient
- Particle size
- Gastrointestinal pH
- Polymorphism
- Interactions with excipients
- Temperature and humidity
In addition, some substances exhibit high lipophilicity, meaning they interact more readily with fats than with water. This characteristic can hinder their performance in the human body, where aqueous environments predominate.
Technologies to improve drug dissolution
The pharmaceutical industry has developed numerous strategies to address dissolution problems and enhance bioavailability.
Particle size reduction
Reducing particle size increases the surface area available for contact, promoting faster dissolution.
Solid dispersions
These systems allow the active ingredient to be distributed within polymeric matrices, improving its performance in biological environments.
Pharmaceutical nanotechnology
Nanoparticles have demonstrated significant potential for increasing bioavailability in certain therapeutic applications.
Advanced drug delivery systems
These include:
- Liposomes
- Micelles
- Cyclodextrin complexes
These technologies enable the encapsulation of poorly soluble molecules, facilitating their transport and absorption.
The role of excipients in dissolution
Excipients are no longer considered inert components.
Today, they are recognized as key elements influencing drug performance. Certain functional excipients directly affect:
- Dissolution rate
- Drug stability
- Biopharmaceutical performance
Examples include surfactants, wetting agents, and specialized polymers.
An inappropriate selection of excipients can significantly alter the overall performance of a medication.
The impact of dissolution problems on the pharmaceutical industry
Dissolution problems do not affect only clinical efficacy. They also have implications for:
- Industrial manufacturing
- Batch-to-batch consistency
- Scale-up processes
- Regulatory approval
Dissolution testing is part of the quality control requirements imposed by health authorities to ensure product quality and reproducibility.
In this regard, organizations such as the European Medicines Agency (EMA) establish guidelines and technical requirements to ensure that dissolution methods used in pharmaceutical development are reproducible, robust, and suitable for guaranteeing drug quality.
Today, pharmaceutical companies increasingly rely on computational simulation, artificial intelligence, and predictive models to anticipate and address these behaviors.
Frequently Asked Questions
- What are dissolution problems in medications? They are difficulties encountered by an active pharmaceutical ingredient in dissolving properly within biological fluids, which may reduce its absorption and therapeutic effectiveness.
- Why is drug dissolution important? Because it is an essential prerequisite for drug absorption in the body and directly determines bioavailability.
- What factors affect the dissolution of a medication? Factors include particle size, pH, crystalline form, polymorphism, and interactions with excipients, among others.
- How can dissolution problems be solved? Through technologies such as particle size reduction, solid dispersions, nanotechnology, or advanced systems such as liposomes and cyclodextrin complexes.
- What is the relationship between dissolution and bioavailability? Improved dissolution generally increases a drug’s bioavailability, thereby enhancing its therapeutic effectiveness.
